enVVeno Medical Statistics
Total Valuation
NVNO has a market cap or net worth of $69.51 million. The enterprise value is $24.50 million.
| Market Cap | 69.51M |
| Enterprise Value | 24.50M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NVNO has 13.32 million shares outstanding. The number of shares has increased by 9.54% in one year.
| Shares Outstanding | 13.32M |
| Shares Change (YoY) | +9.54% |
| Shares Change (QoQ) | +9.53% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 34.94% |
| Float | 12.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.50 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 34.23, with a Debt / Equity ratio of 0.03.
| Current Ratio | 34.23 |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -70.20% and return on invested capital (ROIC) is -53.02%.
| Return on Equity (ROE) | -70.20% |
| Return on Assets (ROA) | -64.70% |
| Return on Capital (ROIC) | -53.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$758,581 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.99% in the last 52 weeks. The beta is 1.12, so NVNO's price volatility has been higher than the market average.
| Beta (1Y) | 1.12 |
| 52-Week Price Change | +31.99% |
| 50-Day Moving Average | 5.52 |
| 200-Day Moving Average | 4.86 |
| Relative Strength Index (RSI) | 50.62 |
| Average Volume (30 Days) | 133,574 |
Short Selling Information
The latest short interest is 821,928, so 6.17% of the outstanding shares have been sold short.
| Short Interest | 821,928 |
| Short Previous Month | 856,514 |
| Short % of Shares Out | 6.17% |
| Short % of Float | 6.55% |
| Short Ratio (days to cover) | 4.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.24M |
| Pretax Income | -23.52M |
| Net Income | -23.52M |
| EBITDA | -22.97M |
| EBIT | -23.52M |
| Earnings Per Share (EPS) | -$1.91 |
Balance Sheet
The company has $46.41 million in cash and $1.40 million in debt, giving a net cash position of $45.01 million or $3.38 per share.
| Cash & Cash Equivalents | 46.41M |
| Total Debt | 1.40M |
| Net Cash | 45.01M |
| Net Cash Per Share | $3.38 |
| Equity / Book Value | 46.20M |
| Book Value Per Share | 3.47 |
| Working Capital | 45.55M |
Cash Flow
In the last 12 months, operating cash flow was -$18.86 million and capital expenditures -$33,000, giving a free cash flow of -$18.89 million.
| Operating Cash Flow | -18.86M |
| Capital Expenditures | -33,000 |
| Free Cash Flow | -18.89M |
| FCF Per Share | -$1.54 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NVNO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.54% |
| Shareholder Yield | -9.54% |
| Earnings Yield | -33.83% |
| FCF Yield | -27.18% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 30, 2020. It was a reverse split with a ratio of 1:25.
| Last Split Date | Nov 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |